Clinical trial design change implementation for inclusive studies

Manuel R. Espinoza-Gutarra; Jack Aiello; Robert Z. Orlowski; Sikander Ailawadhi

doi:10.1016/S2352-3026(23)00336-8

Clinical trial design change implementation for inclusive studies

Manuel R. Espinoza-Gutarra, Jack Aiello, Robert Z. Orlowski, Sikander Ailawadhi

Lymphoma-Myeloma

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	e953-e954
Journal	The Lancet Haematology
Volume	10
Issue number	12
DOIs	https://doi.org/10.1016/S2352-3026(23)00336-8
State	Published - Dec 2023

ASJC Scopus subject areas

Hematology

Access to Document

10.1016/S2352-3026(23)00336-8

Cite this

@article{da4b0832ceed4207a446e306933d551a,

title = "Clinical trial design change implementation for inclusive studies",

author = "Espinoza-Gutarra, {Manuel R.} and Jack Aiello and Orlowski, {Robert Z.} and Sikander Ailawadhi",

year = "2023",

month = dec,

doi = "10.1016/S2352-3026(23)00336-8",

language = "English (US)",

volume = "10",

pages = "e953--e954",

journal = "The Lancet Haematology",

issn = "2352-3026",

publisher = "Lancet Publishing Group",

number = "12",

}

TY - JOUR

T1 - Clinical trial design change implementation for inclusive studies

AU - Espinoza-Gutarra, Manuel R.

AU - Aiello, Jack

AU - Orlowski, Robert Z.

AU - Ailawadhi, Sikander

PY - 2023/12

Y1 - 2023/12

UR - http://www.scopus.com/inward/record.url?scp=85178247302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85178247302&partnerID=8YFLogxK

U2 - 10.1016/S2352-3026(23)00336-8

DO - 10.1016/S2352-3026(23)00336-8

M3 - Comment/debate

C2 - 38030317

AN - SCOPUS:85178247302

SN - 2352-3026

VL - 10

SP - e953-e954

JO - The Lancet Haematology

JF - The Lancet Haematology

IS - 12

ER -

Clinical trial design change implementation for inclusive studies

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this